(Q35803737)

10 August 2017

Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction (English)

1 reference

10 August 2017

0 references

1 reference

1 reference

H Stass

1

1 reference

10 August 2017

D Kubitza

series ordinal

2

1 reference

10 August 2017

A Halabi

series ordinal

3

1 reference

10 August 2017

H Delesen

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

British Journal of Clinical Pharmacology

10 August 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 August 2017

53

1 reference

10 August 2017

3

1 reference

10 August 2017

232-237

1 reference

Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874314

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874314

Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874314

Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874314

Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874314

Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874314

Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874314

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11874385

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11874385

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.0306-5251.2001.01557.X

1 reference

10 August 2017

1 reference

10 August 2017

1 reference